Henric Bjorn Bjarke, SVP, COO at Inozyme Pharma, Inc. (INZY), bought 27,100 shares at $3.69 ($100K) on 2022-04-19, disclosed to the SEC on 2022-04-20.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |